Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,131,301 | -600,093 | -436,367 | -248,705 | -187,091 |
| Depreciation Amortization | -11,273 | -32,741 | -12,896 | 6,578 | 10,344 |
| Income taxes - deferred | N/A | -762 | -3,910 | -419 | N/A |
| Accounts receivable | N/A | 1,254 | 3,419 | 1,256 | 464 |
| Accounts payable and accrued liabilities | 9,535 | -6,465 | 32,469 | 7,288 | 2,239 |
| Other Working Capital | 86,823 | 1,168 | 40,662 | -13,070 | 8,724 |
| Other Operating Activity | 148,475 | 80,203 | 26,051 | 22,671 | 18,140 |
| Operating Cash Flow | $-897,741 | $-557,436 | $-350,572 | $-224,401 | $-147,180 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 134,048 | -544,086 | -334,869 | -13,300 | -135,589 |
| PPE Investments | -15,990 | -10,308 | -7,729 | -10,816 | -6,528 |
| Investing Cash Flow | $118,058 | $-554,394 | $-342,598 | $-24,116 | $-142,117 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 244,215 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 377,089 | 959,129 | 1,233,226 | 301,390 | 294,603 |
| Other Financing Activity | 220 | 284 | -4,026 | 42 | -424 |
| Financing Cash Flow | $621,524 | $959,413 | $1,229,200 | $301,432 | $294,179 |
| Beginning Cash Position | 546,762 | 699,179 | 163,149 | 110,234 | 105,352 |
| End Cash Position | 388,603 | 546,762 | 699,179 | 163,149 | 110,234 |
| Net Cash Flow | $-158,159 | $-152,417 | $536,030 | $52,915 | $4,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | -897,741 | -557,436 | -350,572 | -224,401 | -147,180 |
| Capital Expenditure | -15,990 | -10,308 | -7,729 | -10,816 | -6,528 |
| Free Cash Flow | -913,731 | -567,744 | -358,301 | -235,217 | -153,708 |